Critical evaluation of promotional drug literature based on the WHO criteria

Simple item page
dc.contributor.authorPandit, Sen_US
dc.contributor.authorRhythmen_US
dc.date.accessioned2023-06-27T06:39:34Z
dc.date.available2023-06-27T06:39:34Z
dc.date.issued2022-12
dc.description.abstractBackground: Pharmaceutical companies use drug promotional literature (DPL) as an important mode to promote their products and it also influences the prescribing behavior of prescribers. However, information provided in promotional literature may be inadequate or misleading which may lead to irrational prescribing. The WHO has provided ethical criteria for medicinal drug promotion. Aims and Objectives: This study was undertaken with the aim to analyze the promotional drug literature for their compliance to the WHO ethical criteria for medicinal drug promotion, 1988. Materials and Methods: A cross-sectional and observational study was carried out to evaluate the extent to which promotional literature collected from private physicians meet the WHO ethical criteria for medicinal drug promotion. A total of 100 promotional literature were evaluated for their fulfillment of the WHO criteria. Results: Information regarding brand name, generic name of drugs, dosage form, therapeutic uses, and active ingredient per dosage form was present in most of the promotional drug literature in the present study. However, the information such as safety profile of drugs, precautions, warnings, and drug interactions was not mentioned in most of the DPLs. Conclusion: The majority of DPLs evaluated in this study did not comply with the WHO guidelines for medical drug promotion. As prescribing behavior of physicians is influenced by promotional literatures, regular training of health professionals and medical students regarding critical analysis of DPLs can help in ethical and rational prescribing.en_US
dc.identifier.affiliationsDepartment of Pharmacology, R D Gardi Medical College, Ujjain, Madhya Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology, American International Institute of Medical Sciences, Udaipur, Rajasthan, Indiaen_US
dc.identifier.citationPandit S, Rhythm. Critical evaluation of promotional drug literature based on the WHO criteria. National Journal of Physiology, Pharmacy and Pharmacology. 2022 Dec; 12(12): 2033-2036en_US
dc.identifier.issn2231-3206
dc.identifier.issn2320-4672
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/217822
dc.languageenen_US
dc.publisherMrs Dipika Charan of MedScience (India) Publicationsen_US
dc.relation.issuenumber12en_US
dc.relation.volume12en_US
dc.source.urihttps://dx.doi.org/10.5455/njppp.2022.12.04171202211042022en_US
dc.subjectDrug Promotional Literatureen_US
dc.subjectPharmaceutical Companiesen_US
dc.subjectWHOen_US
dc.titleCritical evaluation of promotional drug literature based on the WHO criteriaen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
NJPPP2022v12n12p2033.pdf
Size:
207.94 KB
Format:
Adobe Portable Document Format
Download
Collections
National Journal of Physiology, Pharmacy and Pharmacology